07.05.2021

Vaccine for children aged 12 to 15: Pfizer submits authorisation application to Swissmedic

The vaccine "Comirnaty®" is currently authorised for people aged 16 and over. The application asks for the authorisation to be extended to include the age group of 12-15-year-olds.

07.05.2021

Side effects of COVID-19 vaccines in Switzerland – update

1953 reports of suspected adverse reactions to COVID-19 vaccines in Switzerland evaluated

06.05.2021

Market surveillance of COVID-19 vaccines: reporting suspected side effects correctly

Reporting ADRs: important information for healthcare professionals and vaccinated individuals

05.05.2021

Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

05.05.2021

Swissmedic Journal

Latest edition
Swissmedic Journal April 2021

04.05.2021

International trade with wholesalers outside the EU

Licence holders required to check suppliers more rigorously

04.05.2021

HPC – Micotil 300 ad us. vet.

Neue Wartezeit für essbares Gewebe: 70 Tage

22.04.2021

Side effects of COVID-19 vaccines in Switzerland – update

1485 reports of suspected adverse reactions to COVID-19 vaccines in Switzerland evaluated

In focus

Covid-19-Fokus

19.04.2021

Coronavirus disease (COVID-19) Pandemic

Information on the new coronavirus (SARS-CoV-2)

Vaccines against COVID-19

Product information

COVID-19 vaccines on the Swiss market

Approved batches

Restricted phone availability – please write to us instead!

Due to the COVID-19 pandemic, Swissmedic is currently receiving more queries than usual. We are therefore unable to receive telephone enquiries. Please submit your questions to us by e-mail (anfragen@swissmedic.ch).

Thank you for bearing with us.

Direct links


Stay up to date


Incident reporting

Medicines

Reporting undesirable effects


Medical devices

Reporting incidents & FSCAs

Featured


Medizinprodukte

27.04.2021

New medical devices regulations

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

04.12.2018

Therapeutic Products Legislation update

The modifications following the ordinary revision of the TPA and its right of enforcement will enter into force on 1 January 2019

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html